[go: up one dir, main page]

CN116251235A - Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method - Google Patents

Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method Download PDF

Info

Publication number
CN116251235A
CN116251235A CN202211611478.9A CN202211611478A CN116251235A CN 116251235 A CN116251235 A CN 116251235A CN 202211611478 A CN202211611478 A CN 202211611478A CN 116251235 A CN116251235 A CN 116251235A
Authority
CN
China
Prior art keywords
calcium phosphate
self
curing
sponge
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211611478.9A
Other languages
Chinese (zh)
Inventor
周宏志
薛洋
何峰
李元
郑雪妮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fourth Military Medical University FMMU
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CN202211611478.9A priority Critical patent/CN116251235A/en
Publication of CN116251235A publication Critical patent/CN116251235A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明属于口腔医学临床应用材料与器械技术领域,涉及一种多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法,所述制备方法包括以下步骤:1)、将医用明胶海绵或胶原海绵粉碎制成粒径为0.1‑2mm的海绵颗粒;2)、将所述海绵颗粒与自固化磷酸钙的粉剂均匀混合在一起后形成混合物备用;3)、将所述自固化磷酸钙的液剂加入所述混合物,调拌均匀后形成糊剂;4)、所述糊剂固化后得到多孔骨引导/诱导骨自固化磷酸钙复核材料。其能够提高材料引导/诱导骨再生的效率、材料临床应用的可靠性和便捷性等,适用不同部位/大小骨缺损的再生修复,且适用与口腔局部用抗菌药物的复合应用。The invention belongs to the technical field of materials and instruments for clinical application in stomatology, and relates to a porous osteoconductive/induced self-curing calcium phosphate composite material and a preparation method thereof. The preparation method comprises the following steps: 1), medical gelatin sponge or collagen sponge Pulverize and make the sponge particle that particle diameter is 0.1-2mm; 2), the powder of described sponge particle and self-curing calcium phosphate is uniformly mixed together and form mixture standby; 3), the liquid of described self-curing calcium phosphate Add the mixture, mix it evenly, and form a paste; 4) After the paste is cured, a porous osteoconductive/bone-induced self-curing calcium phosphate re-examination material is obtained. It can improve the efficiency of material guidance/induction of bone regeneration, the reliability and convenience of clinical application of materials, etc., and is suitable for the regeneration and repair of bone defects in different parts/sizes, and is suitable for composite application with local oral antibacterial drugs.

Description

多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method

技术领域technical field

本发明属于口腔医学临床应用材料与器械技术领域,涉及一种引导/诱导骨再生材料/器械的制备方法,尤其是一种多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法。The invention belongs to the technical field of materials and devices for clinical application in stomatology, and relates to a preparation method of a guiding/inducing bone regeneration material/device, in particular to a porous bone guiding/inducing self-curing calcium phosphate composite material and a preparation method thereof.

背景技术Background technique

由于各种牙源性炎症、肿瘤和口腔颌面部外伤引起的牙槽骨/颌骨缺损是口腔医学领域最为常见的疾病,会严重影响口腔牙列完整美观,导致口腔咀嚼和语言功能受损乃至面部畸形。Alveolar bone/jaw bone defects caused by various odontogenic inflammations, tumors and oral and maxillofacial trauma are the most common diseases in the field of stomatology, which will seriously affect the integrity and appearance of oral dentition, resulting in impaired oral mastication and language functions even facial deformities.

当前临床修复牙槽骨/颌骨缺损的主要技术包括自体骨移植、骨替代材料植入骨缺损、生物引导膜保护骨缺损等。自体骨移植目前仍是骨缺损修复效果最为理想的手段,但移植手术较为复杂,技术要求较高,供骨区有额外损伤,常见因术后感染等原因导致骨移植失败,患者损失较大。因此,采用人工材料替代自体骨移植修复骨缺损、重建骨结构是当代医学重要研究方向。The current main clinical techniques for repairing alveolar bone/jaw defects include autologous bone grafting, implantation of bone substitute materials into bone defects, and bioguiding membranes to protect bone defects. Autologous bone transplantation is still the most ideal method for repairing bone defects, but the transplantation operation is more complicated, with higher technical requirements, additional damage to the bone donor site, common causes of bone graft failure due to postoperative infection and other reasons, and great losses to patients. Therefore, using artificial materials instead of autologous bone grafts to repair bone defects and reconstruct bone structure is an important research direction of contemporary medicine.

人工材料主要通过引导/诱导骨再生的机制修复骨缺损,即,材料植入体内后逐步降解,同时引导/诱导周围骨组织中的干细胞分化、成骨细胞增殖、血管新生并长入,形成新骨组织,替代原有材料,实现骨再生。现有常用的人工骨引导/诱导材料多为颗粒状,便于植入不规则骨腔,但没有负载支撑能力,植入过程中填塞紧密程度不同,会影响其内部孔隙率和引导骨再生效率。此外,一般需要与生物引导膜共同应用,利用生物膜的屏障作用,保护植骨颗粒,避免流失,同时阻挡周围软组织中生长较快的成纤维细胞或上皮细胞等长入、避免其干扰生长较慢的成骨细胞和血管增殖与新生,获得理想的骨再生效果。这些问题影响了颗粒状人工植骨材料的适用范围、临床应用便捷性和可靠性。Artificial materials mainly repair bone defects through the mechanism of guiding/inducing bone regeneration, that is, after the material is implanted in the body, it gradually degrades, and at the same time guides/induces stem cell differentiation, osteoblast proliferation, angiogenesis and ingrowth in the surrounding bone tissue to form new bone defects. Bone tissue replaces the original material to achieve bone regeneration. The commonly used artificial bone conduction/induction materials are mostly granular, which is convenient for implantation into irregular bone cavities, but has no load-bearing capacity, and the degree of packing density varies during implantation, which will affect its internal porosity and guided bone regeneration efficiency. In addition, it is generally required to be used together with the bioguiding membrane, and the barrier function of the biofilm is used to protect the bone graft particles from loss, and at the same time prevent the growth of fast-growing fibroblasts or epithelial cells in the surrounding soft tissue, and avoid their interference with growth. Slow proliferation and regeneration of osteoblasts and blood vessels to obtain ideal bone regeneration effect. These problems have affected the scope of application, convenience and reliability of clinical application of granular artificial bone graft materials.

因此,鉴于现有骨再生临床材料存在较明显不足,迫切需要研制一种新型的口腔科用多孔骨引导/诱导复合材料及其制备方法。Therefore, in view of the obvious shortcomings of existing bone regeneration clinical materials, it is urgent to develop a new type of porous osteoconductive/inductive composite material for stomatology and its preparation method.

发明内容Contents of the invention

本发明的目的在于克服现有材料中存在的缺点,提供一种多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法,其能够提高材料引导/诱导骨再生的效率、材料临床应用的可靠性和便捷性等,适用不同部位/大小骨缺损的再生修复,且适用与口腔局部用抗菌药物的复合应用。The purpose of the present invention is to overcome the shortcomings existing in the existing materials, to provide a porous bone conduction/induced self-curing calcium phosphate composite material and its preparation method, which can improve the efficiency of material guidance/induced bone regeneration and the reliability of the clinical application of the material It is suitable for regenerative repair of bone defects in different parts/sizes, and it is also suitable for compound application with local oral antibacterial drugs.

为了实现上述目的,本发明提供如下技术方案:In order to achieve the above object, the present invention provides the following technical solutions:

一种多孔骨引导/诱导自固化磷酸钙复合材料的制备方法,其特征在于,包括以下步骤:A method for preparing a porous osteoconductive/inducible self-solidifying calcium phosphate composite material, characterized in that it comprises the following steps:

1)、将医用明胶海绵或胶原海绵粉碎,制成粒径为0.1-2mm的海绵颗粒;1), crush medical gelatin sponge or collagen sponge to make sponge particles with a particle size of 0.1-2mm;

2)、将所述海绵颗粒与自固化磷酸钙的粉剂均匀混合在一起后形成混合物;2), the powder of described sponge particle and self-curing calcium phosphate is uniformly mixed together to form a mixture;

3)、将自固化磷酸钙的液剂加入所述混合物中,调拌均匀后形成糊剂;3), adding the liquid agent of self-curing calcium phosphate into the mixture, forming a paste after mixing evenly;

4)、所述糊剂固化后得到多孔骨引导/诱导骨自固化磷酸钙复合材料。4) After the paste is cured, a porous bone-conducting/bone-inducing self-curing calcium phosphate composite material is obtained.

优选地,所述步骤2)中,在混合时,所述海绵颗粒的体积与所述自固化磷酸钙的粉剂的质量比的范围为1-2cm3/g。Preferably, in the step 2), when mixing, the mass ratio of the volume of the sponge particles to the self-curing calcium phosphate powder is in the range of 1-2 cm 3 /g.

优选地,所述步骤3)中,所述自固化磷酸钙的液剂的体积与所述混合物中的自固化磷酸钙的粉剂的质量的比的范围为0.3-0.5ml/g。Preferably, in the step 3), the ratio of the volume of the self-curing calcium phosphate liquid to the mass of the self-solidifying calcium phosphate powder in the mixture is in the range of 0.3-0.5ml/g.

优选地,所述医用明胶海绵或胶原海绵粉为临床常规止血用明胶海绵或胶原海绵。Preferably, the medical gelatin sponge or collagen sponge powder is a gelatin sponge or collagen sponge for routine clinical hemostasis.

优选地,所述自固化磷酸钙的粉剂为医用自固化磷酸钙人工骨。Preferably, the self-curing calcium phosphate powder is medical self-curing calcium phosphate artificial bone.

优选地,所述步骤1)中,采用破壁机或组织匀浆机将医用明胶海绵或胶原海绵粉碎。Preferably, in the step 1), the medical gelatin sponge or collagen sponge is pulverized by using a wall breaking machine or a tissue homogenizer.

优选地,所述自固化磷酸钙的液剂为水或含有钙或磷酸盐的溶液。Preferably, the liquid agent of self-curing calcium phosphate is water or a solution containing calcium or phosphate.

此外,本发明还提供一种多孔骨引导/诱导自固化磷酸钙复合材料,其特征在于,其采用上述方法制备而成。In addition, the present invention also provides a porous osteoconductive/inducible self-solidifying calcium phosphate composite material, which is characterized in that it is prepared by the above method.

与现有技术相比,本发明的多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法具有如下有益技术效果中的一者或多者:Compared with the prior art, the porous osteoconductive/inducible self-solidifying calcium phosphate composite material and its preparation method of the present invention have one or more of the following beneficial technical effects:

1、本发明首次实现了两种临床材料/器械同时使用,提高引导/诱导骨再生效率,在临床应用的便捷性、可靠性、经济性、适用性等多方面都具有独特的优势。1. The present invention realizes the simultaneous use of two clinical materials/devices for the first time, improves the efficiency of guiding/inducing bone regeneration, and has unique advantages in the convenience, reliability, economy, applicability and other aspects of clinical application.

2、本发明制备的多孔骨引导/诱导自固化磷酸钙复合材料,具有孔隙率高,孔隙分布均匀,材料自行结固,结固前有充分可塑性,结固后有较好的强度,可吸收性且吸收降解时间与松质骨相当,使用方便,操作简单,维持骨再生空间可靠,适用于各种简单或复杂骨缺损或骨腔的引导/诱导骨再生治疗。2. The porous osteoconductive/induced self-curing calcium phosphate composite material prepared by the present invention has high porosity, uniform distribution of pores, self-consolidation of the material, sufficient plasticity before consolidation, good strength after consolidation, and can absorb It is stable and the absorption and degradation time is equivalent to that of cancellous bone. It is convenient to use, simple to operate, and reliable to maintain bone regeneration space. It is suitable for guided/induced bone regeneration treatment of various simple or complex bone defects or bone cavities.

3、本发明制备的多孔骨引导/诱导自固化磷酸钙复合材料,可通过与临床常用牙科抗菌药物制剂联合应用,如与米诺环素复合,实现抗菌药物加载,植入体内后,随材料逐渐降解,能持续缓释具有抗感染和诱导骨再生作用的米诺环素,有效避免局部感染,减轻有菌环境对骨再生过程的干扰,提高引导骨再生修复骨缺损的效果与成功率。3. The porous osteoconductive/inducible self-curing calcium phosphate composite material prepared by the present invention can be used in combination with commonly used clinical dental antibacterial drug preparations, such as compounding with minocycline, to achieve antibacterial drug loading. Gradually degraded, it can continuously and slowly release minocycline with anti-infection and bone regeneration-inducing effects, effectively avoid local infection, reduce the interference of bacterial environment on the bone regeneration process, and improve the effect and success rate of guided bone regeneration to repair bone defects.

具体实施方式Detailed ways

下面结合实施例对本发明进一步说明,实施例的内容不作为对本发明的保护范围的限制。The present invention will be further described below in conjunction with the examples, and the contents of the examples are not intended to limit the protection scope of the present invention.

自固化磷酸钙(Calcium phosphate cement,CPC)在构建复合生物材料方面,具有独特优势。CPC也被称为磷酸钙骨水泥,以固相的粉剂和液相的液剂分别保存,粉剂是由几种磷酸钙盐混合而成的粉状物,包括磷酸四钙(TTCP)、无水磷酸氢钙(DCPA)等,使用时,与液剂,即水或添加其他成分的水溶液调和,能够发生化学反应自行固化,固化反应温和,可以非常方便的与各种有机成分混合固化。固化过程中可随意塑形,固化后形成羟基磷灰石结晶等为主要成分的材料,能够承担一定负载,具有引导成骨活性和良好的生物相容性,不需要生物引导膜的屏障和保护作用,临床应用相对简便和便宜,是骨再生研究和临床应用中的重要材料,并且是生物活性分子较为理想的无机载体。但是单纯CPC材料与天然骨基质的成分、结构和功能仍有较大差距,主要的问题包括:固化孔隙率较低、不具有动员诱导细胞分化能力、体内降解转化速度慢等。Self-solidifying calcium phosphate (Calcium phosphate cement, CPC) has unique advantages in the construction of composite biomaterials. CPC, also known as calcium phosphate bone cement, is stored separately in solid-phase powder and liquid-phase liquid. The powder is a mixture of several calcium phosphate salts, including tetracalcium phosphate (TTCP), anhydrous Calcium hydrogen phosphate (DCPA), etc., when used, mixed with liquid agent, that is, water or an aqueous solution with other components, can undergo a chemical reaction and self-cure. The curing reaction is mild, and it can be mixed and cured with various organic components very conveniently. During the curing process, it can be shaped freely, and after curing, it will form a material with hydroxyapatite crystals as the main component, which can bear a certain load, has guiding osteogenic activity and good biocompatibility, and does not require the barrier and protection of a biological guiding film It is an important material in bone regeneration research and clinical application, and it is an ideal inorganic carrier for bioactive molecules. However, the composition, structure, and function of simple CPC materials and natural bone matrix still have a large gap. The main problems include: low curing porosity, no ability to mobilize and induce cell differentiation, and slow degradation and transformation in vivo.

明胶或胶原海绵是由动物皮/骨等组织的细胞外基质经过不同物理、化学加工过程制得,有止血和支持、保护、连接组织愈合等多种作用,有良好的血小板凝聚性能,与各种组织细胞、生长因子有较好的亲和性,医用明胶、胶原是临床常规止血材料,生物降解性能突出,价格便宜,安全可靠。Gelatin or collagen sponge is made from the extracellular matrix of animal skin/bone and other tissues through different physical and chemical processes. It has various functions such as hemostasis, support, protection, and connection tissue healing. Tissue cells and growth factors have good affinity. Medical gelatin and collagen are routine clinical hemostatic materials with outstanding biodegradability, cheap price, safety and reliability.

如果将明胶/胶原与自固化磷酸钙材料进行复合,明胶/胶原海绵能够在自固化磷酸钙材料内部形成孔隙结构,利于组织液/氧气/细胞等渗透,利于引导/诱导骨再生;并且,两者混合基本不影响材料的可塑形,便于填充不规则的骨缺损或骨再生空间;同时,固化后能够形成稳定的支架结构,能够承受一定负载,可望用于即刻种植牙或早期种植牙的种植体表面包被、牙槽嵴拔牙窝位点保存、牙槽骨/颌骨缺损填充等多种临床治疗过程;材料能与周围骨质紧密接触,并且接触面积广泛,骨引导作用强;固体材料流失少,填充后自行结固,孔隙率稳定,受临床操作影响小;无需与生物膜引导技术联合应用,减少医疗费用支出,简便临床手术操作。If the gelatin/collagen is combined with the self-curing calcium phosphate material, the gelatin/collagen sponge can form a pore structure inside the self-curing calcium phosphate material, which is conducive to the penetration of tissue fluid/oxygen/cells, etc., and is conducive to guiding/inducing bone regeneration; and, both Mixing basically does not affect the plasticity of the material, which is convenient for filling irregular bone defects or bone regeneration spaces; at the same time, it can form a stable scaffold structure after curing, which can withstand a certain load, and is expected to be used for immediate or early implant implants Body surface coating, alveolar ridge extraction socket site preservation, alveolar bone/jaw bone defect filling and other clinical treatment processes; the material can be in close contact with the surrounding bone, and the contact area is wide, and the bone conduction effect is strong; solid material Less loss, self-consolidation after filling, stable porosity, less affected by clinical operations; no need for combined application with biofilm guidance technology, reducing medical expenses and facilitating clinical operations.

此外,口腔环境是有菌环境,牙槽骨/颌骨缺损常难以与口腔环境完全隔离和封闭,细菌对引导骨再生过程有较为显著的不利影响,可导致愈合时间延长甚至导致术后感染,骨缺损修复失败。CPC缓释载体能力,使其能与口腔抗菌药物复合应用,实现抗菌能力的持续缓释,提高材料的抗炎和抗感染性质。In addition, the oral environment is a bacterial environment. It is often difficult to completely isolate and seal alveolar bone/jaw bone defects from the oral environment. Bacteria have a significant adverse effect on the guided bone regeneration process, which can lead to prolonged healing time and even lead to postoperative infection. Failed bone defect repair. The slow-release carrier capability of CPC enables it to be combined with oral antibacterial drugs to achieve sustained and sustained release of antibacterial ability and improve the anti-inflammatory and anti-infective properties of the material.

基于此,发明人发明了一种多孔骨引导/诱导自固化磷酸钙复合材料及其制备方法,其采用医用明胶海绵或胶原海绵与自固化磷酸钙材料相结合,能够提高材料引导/诱导骨再生的效率、材料临床应用的可靠性和便捷性等,适用不同部位/大小骨缺损的再生修复,且适用与口腔局部用抗菌药物的复合应用。Based on this, the inventors have invented a porous bone-conducting/inducing self-curing calcium phosphate composite material and its preparation method, which uses medical gelatin sponge or collagen sponge combined with self-curing calcium phosphate material, which can improve material guiding/inducing bone regeneration The efficiency, reliability and convenience of clinical application of materials, etc., are suitable for the regenerative repair of bone defects in different parts/sizes, and are suitable for compound application with local oral antibacterial drugs.

具体地,本发明的多孔骨引导/诱导自固化磷酸钙复合材料的制备方法包括以下步骤:Specifically, the preparation method of the porous osteoconductive/induced self-curing calcium phosphate composite material of the present invention comprises the following steps:

一、将医用明胶海绵或胶原海绵粉碎,制成粒径为0.1-2mm的海绵颗粒。1. Crush the medical gelatin sponge or collagen sponge to make sponge particles with a particle size of 0.1-2mm.

其中,所述医用明胶海绵或胶原海绵粉可以为临床常规止血用明胶海绵或胶原海绵。Wherein, the medical gelatin sponge or collagen sponge powder can be gelatin sponge or collagen sponge for routine clinical hemostasis.

优选地,在粉碎时,可以采用破壁机或组织匀浆机将医用明胶海绵或胶原海绵粉碎成大小均匀的小颗粒。Preferably, when pulverizing, a wall breaking machine or a tissue homogenizer can be used to pulverize the medical gelatin sponge or collagen sponge into small particles of uniform size.

二、将所述海绵颗粒与自固化磷酸钙的粉剂均匀混合在一起后形成混合物。2. The sponge particles and the powder of self-curing calcium phosphate are evenly mixed together to form a mixture.

所述自固化磷酸钙由粉剂和液剂组成。粉剂包括多种磷酸钙化合物,液剂为水或含有钙或磷酸盐的溶液,两者混合后形成糊剂,能发生化学反应逐渐凝结硬化成固体,产生的最终产物为钙磷石(二水磷酸二钙)或磷灰石(羟基磷灰石或缺钙羟基磷灰石)。The self-curing calcium phosphate consists of powder and liquid. The powder includes a variety of calcium phosphate compounds. The liquid is water or a solution containing calcium or phosphate. The two are mixed to form a paste, which can undergo a chemical reaction and gradually condense and harden into a solid. The final product produced is brushite (dihydrate dicalcium phosphate) or apatite (hydroxyapatite or calcium-deficient hydroxyapatite).

优选地,所述自固化磷酸钙的粉剂为医用自固化磷酸钙人工骨。Preferably, the self-curing calcium phosphate powder is medical self-curing calcium phosphate artificial bone.

在本发明中,在混合时,所述海绵颗粒的体积与所述自固化磷酸钙的粉剂的质量比的范围为1-2cm3/g。也就是,每1-2cm3的所述海绵颗粒与1g的所述自固化磷酸钙的粉剂均匀混合在一起。经过大量的医学实验发现,采用这种比例进行混合,能够有助于保证制备的复合材料的多孔性,并能够使得制备的复合材料具有足够的支撑性。In the present invention, when mixing, the mass ratio of the volume of the sponge particles to the self-curing calcium phosphate powder ranges from 1 to 2 cm 3 /g. That is, every 1-2cm 3 of the sponge particles are uniformly mixed with 1g of the self-curing calcium phosphate powder. After a large number of medical experiments, it is found that mixing in this ratio can help ensure the porosity of the prepared composite material, and can make the prepared composite material have sufficient support.

三、将自固化磷酸钙的液剂加入所述混合物中,调拌均匀后形成糊剂。3. Add the liquid agent of self-curing calcium phosphate into the mixture, mix well and form a paste.

优选地,所述自固化磷酸钙的液剂为水或含有钙或磷酸盐的溶液。Preferably, the liquid agent of self-curing calcium phosphate is water or a solution containing calcium or phosphate.

并且,所述自固化磷酸钙的液剂的体积与所述混合物中的自固化磷酸钙的粉剂的质量的比的范围为0.3-0.5ml/g。也就是,在加入液剂时,将0.3-0.5ml的液剂加入到含有1g粉剂的混合物中。经过大量的医学实验发现,采用这种比例进行混合,能够有助于制备的复合材料的固化。In addition, the ratio of the volume of the self-solidifying calcium phosphate liquid to the mass of the self-solidifying calcium phosphate powder in the mixture is in the range of 0.3-0.5ml/g. That is, when adding the liquid, 0.3-0.5 ml of the liquid is added to the mixture containing 1 g of the powder. After a large number of medical experiments, it was found that mixing with this ratio can help the curing of the prepared composite material.

四、所述糊剂固化后得到多孔骨引导/诱导骨自固化磷酸钙复合材料。4. After the paste is solidified, a porous bone-conducting/bone-inducing self-curing calcium phosphate composite material is obtained.

在固化过程中,通过发生化学反应,使材料硬化,可降解的大量明胶/胶原海绵颗粒均匀分布于其内部,实现孔隙的形成。During the curing process, a chemical reaction occurs to harden the material, and a large number of degradable gelatin/collagen sponge particles are evenly distributed inside it to realize the formation of pores.

在本发明中,可以将所述糊剂用注射器、骨膜剥离器或牙科填塞器等植入骨缺损或生理、病理性骨腔中,填压使其与周围骨壁紧密结合,然后原位自行固化,即能够在骨缺损/骨腔部位得到多孔骨引导/诱导自固化磷酸钙复合材料。In the present invention, the paste can be implanted into a bone defect or a physiological or pathological bone cavity with a syringe, a periosteal stripper, or a dental tampon, and packed to make it tightly bonded to the surrounding bone wall, and then the paste can be self-sufficient in situ. Solidification, that is, porous osteoconductive/induced self-curing calcium phosphate composites can be obtained at bone defects/bone cavities.

此外,在本发明中,可以将所述糊剂与牙科用盐酸米诺环素软膏混合,然后植入骨缺损腔隙内。这样,通过与临床常用牙科抗菌药物制剂联合应用,如与米诺环素复合,可以实现抗菌药物加载,植入体内后,随材料逐渐降解,能持续缓释具有抗感染和诱导骨再生作用的米诺环素,有效避免局部感染,减轻有菌环境对骨再生过程的干扰,提高引导骨再生修复骨缺损的效果与成功率。Furthermore, in the present invention, the paste can be mixed with dental minocycline hydrochloride ointment, and then implanted into the bone defect cavity. In this way, through the combined application of clinically used dental antibacterial drug preparations, such as compounding with minocycline, antibacterial drug loading can be realized. After implantation in the body, the material will gradually degrade, and the anti-infection and bone regeneration-inducing effects can be continuously and slowly released. Minocycline can effectively avoid local infection, reduce the interference of the bacterial environment on the bone regeneration process, and improve the effect and success rate of guided bone regeneration to repair bone defects.

本发明的上述实施例仅仅是为清楚地说明本发明所作的举例,而并非是对本发明的实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无法对所有的实施方式予以穷举。凡是属于本发明的技术方案所引伸出的显而易见的变化或变动仍处于本发明的保护范围之列。The above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, rather than limiting the implementation of the present invention. For those of ordinary skill in the art, other changes or changes in different forms can be made on the basis of the above description. All the implementation manners cannot be exhaustively listed here. All obvious changes or variations derived from the technical solutions of the present invention are still within the protection scope of the present invention.

Claims (8)

1. A method for preparing a porous bone guiding/inducing self-curing calcium phosphate composite material, which is characterized by comprising the following steps:
1) Crushing medical gelatin sponge or collagen sponge to obtain sponge particles with the particle size of 0.1-2 mm;
2) Uniformly mixing the sponge particles with the powder of the self-curing calcium phosphate to form a mixture;
3) Adding the liquid agent of self-curing calcium phosphate into the mixture, and uniformly mixing to form paste;
4) And curing the paste to obtain the porous bone guiding/induced bone self-curing calcium phosphate composite material.
2. The method for preparing a porous bone guiding/inducing self-curing calcium phosphate composite material according to claim 1, wherein in the step 2), the mass ratio of the volume of the sponge particles to the powder of the self-curing calcium phosphate is in the range of 1-2cm at the time of mixing 3 /g。
3. The method of preparing a porous bone guiding/inducing self-setting calcium phosphate composite according to claim 2, wherein in the step 3), the ratio of the volume of the liquid of self-setting calcium phosphate to the mass of the powder of self-setting calcium phosphate in the mixture is in the range of 0.3-0.5ml/g.
4. The method for preparing a porous bone conduction/induction self-curing calcium phosphate composite material according to claim 3, wherein the medical gelatin sponge or collagen sponge powder is a clinically conventional hemostatic gelatin sponge or collagen sponge.
5. The method for preparing a porous bone conduction/induction self-curing calcium phosphate composite material according to claim 4, wherein the powder of self-curing calcium phosphate is medical self-curing calcium phosphate artificial bone.
6. The method for preparing a porous bone guiding/inducing self-curing calcium phosphate composite according to claim 5, wherein in the step 1), a wall breaking machine or a tissue refiner is used to break up the medical gelatin sponge or the collagen sponge.
7. The method of preparing a porous bone conduction/induction self-curing calcium phosphate composite material according to claim 6, wherein the liquid agent of self-curing calcium phosphate is water or a solution containing calcium or phosphate.
8. A porous osteoconductive/inductive self-curing calcium phosphate composite material, characterized in that it is prepared by the method according to any one of claims 1-7.
CN202211611478.9A 2022-12-14 2022-12-14 Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method Pending CN116251235A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211611478.9A CN116251235A (en) 2022-12-14 2022-12-14 Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211611478.9A CN116251235A (en) 2022-12-14 2022-12-14 Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method

Publications (1)

Publication Number Publication Date
CN116251235A true CN116251235A (en) 2023-06-13

Family

ID=86686990

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211611478.9A Pending CN116251235A (en) 2022-12-14 2022-12-14 Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method

Country Status (1)

Country Link
CN (1) CN116251235A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380313A1 (en) * 2002-07-11 2004-01-14 MERCK PATENT GmbH Method of preparing porous calcium phosphate morsels and granules via Gelatin processing
CN1907504A (en) * 2006-07-31 2007-02-07 中山大学附属第一医院 Injectable hydrogel of sodium alginate crosslinked gelatin containing biphase calcium-phosphorus particles and preparation method and application thereof
US20090048145A1 (en) * 2004-06-09 2009-02-19 Scil Technology Gmbh In situ hardening paste, its manufacturing and use
CN103585679A (en) * 2013-11-13 2014-02-19 潘朝晖 Gelatin microsphere composite chitosan fiber framework bone cement and preparation and use methods thereof
CN104523341A (en) * 2014-12-18 2015-04-22 中国人民解放军第四军医大学 Method for manufacturing immediately implanted tooth with periodontal bioactivity
CN104771785A (en) * 2015-04-03 2015-07-15 周宏志 Preparation method of bone repair material with neuropeptide inductive osteogenic activity

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380313A1 (en) * 2002-07-11 2004-01-14 MERCK PATENT GmbH Method of preparing porous calcium phosphate morsels and granules via Gelatin processing
US20090048145A1 (en) * 2004-06-09 2009-02-19 Scil Technology Gmbh In situ hardening paste, its manufacturing and use
CN1907504A (en) * 2006-07-31 2007-02-07 中山大学附属第一医院 Injectable hydrogel of sodium alginate crosslinked gelatin containing biphase calcium-phosphorus particles and preparation method and application thereof
CN103585679A (en) * 2013-11-13 2014-02-19 潘朝晖 Gelatin microsphere composite chitosan fiber framework bone cement and preparation and use methods thereof
CN104523341A (en) * 2014-12-18 2015-04-22 中国人民解放军第四军医大学 Method for manufacturing immediately implanted tooth with periodontal bioactivity
CN104771785A (en) * 2015-04-03 2015-07-15 周宏志 Preparation method of bone repair material with neuropeptide inductive osteogenic activity

Similar Documents

Publication Publication Date Title
US6689375B1 (en) Resorbable bone implant material and method for producing the same
Arcos et al. Bioceramics for drug delivery
Vezenkova et al. Sudoku of porous, injectable calcium phosphate cements–Path to osteoinductivity
CN100408115C (en) Biomaterial film with porous structure and preparation method thereof
Hu et al. Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair
Gkouma et al. Applications of halloysite in tissue engineering
CN100540072C (en) Micropore bone cement and bone cream
JP2003530363A (en) Injectable bone mineral replacement material
US20120071884A1 (en) Mixing and dispensing apparatus for bone void filler
JPH11506659A (en) Biocompatible hydroxyapatite formulations and uses thereof
WO2022088634A1 (en) Injection-type magnesium-based carbon nanotube composite microsphere activated calcium phosphate biological bone adhesive and method for preparation thereof and application thereof
CN101020085A (en) New-type of inorganic bone grafting material and its prepn and use
Moussi et al. Injectable macromolecule-based calcium phosphate bone substitutes
CN102049062B (en) Injectable efficient suspended stable calcium phosphate cement and preparation method and application thereof
Fernandes et al. Calcium sulfate as a scaffold for bone tissue engineering: a descriptive review
CN112190762B (en) An injection-type magnesium-based composite fiber reinforced calcium phosphate biological bone adhesive and its preparation method and application
CN1446589A (en) Medicine controlled functional cement with calcium phosphate being as framework and its preparation method
KR101429857B1 (en) Method for manufacturing composite bilayer fiber mat for bone hemorrhage application
RU2360663C1 (en) Gel for bone tissue repair
Wang et al. Substance P incorporation in calcium phosphate cement for dental alveolar bone defect restoration
Zhu et al. Injectable magnesium oxychloride cement foam-derived scaffold for augmenting osteoporotic defect repair
KR101777427B1 (en) Biomaterials containing calcium phosphate
CN102247599A (en) Slow release system for borate bioglass carried with antibiotic and preparation method thereof
Daculsi et al. The essential role of calcium phosphate bioceramics in bone regeneration
JP4802317B2 (en) Calcium phosphate ceramic bead assembly and method for constructing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination